After finding that type 1 diabetes destroys blood vessels in the pancreas as well as insulin-producing cells, scientists at the University of Missouri are developing a drug called Ig-GAD2 for use in combination with adult stem cells from bone marrow. Lead author Habib Zaghouani said "the bone marrow cells led to growth of new blood vessels, and it was the blood vessels that facilitated reproduction of new beta cells" in preclinical tests. The results appear in the journal Diabetes.

Related Summaries